America's Best Nonprofits
  1. Home
  2. Medical Research
  3. Los Angeles, CA
  4. University Kidney Research Organization

University Kidney Research Organization

University Kidney Research Organization has an America's Best Score of 52 out of 100, based on its 2024 Form 990, below the 60-point bar to be ranked.

  • Los Angeles, CA
  • Tax-exempt since 2002
  • EIN: 03-0459723
ukrocharity.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate
52OF 100 Not ranked Below the 60-point bar How this score is calculated

Organization summary

University Kidney Research Organization is a 501(c)(3) organization, classified under Medical Research (NTEE H12). Contributions are tax-deductible.

1801 Century Park East 24Th Floor, Los Angeles, CA 90067-2302

Among the 15 scored medical research organizations in Los Angeles, University Kidney Research Organization holds 14.5 months of operating reserves (peer median 14.5 months), runs a typical yearly deficit of 29.4% (peers: surplus of 4.0%), and has cut spending 16.8% a year (peers: grown spending 17.0% a year).

In fiscal year 2024 it reported $110,733 in revenue and $238,586 in expenses, with contributions making up 88.1% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2024 Form 990

University Kidney Research Organization supports medical research related to theprevention, treatment, and eradication of kidney disease. Ukro fundraises to supportthe synthetic kidney project at the newly named vito m. Campese, m.d./ukro kidney research center of usc.

Largest programs · fiscal year 2024

  • In April 2024, ukro made a gift of $100,000 to the keck school of medicine of usc to support the synthetic kidney project.in December 2024, ukro made a donor-directed gift of $15,000 to the keck school of medicine of usc to fund the re-hiring of a key researcher on the synthetic kidney project team. $115,000 spent · 88.8% of program spending
  • Through its website, online social media presence, and e-newsletters, the organization raises awareness of kidney disease and research breakthroughs, particularly spotlighting the work of scientists at the newly named vito m. Campese, m.d./ukro kidney research center and the keck school of medicine of usc. $14,502 spent · 11.2% of program spending

Where each dollar went · fiscal year 2024

Of every dollar it spent, 54¢ went to programs, 28¢ to management and 18¢ to fundraising.

  • Programs $129,502
  • Management $65,040
  • Fundraising $44,044

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

America's Best Score

Free assessmentMethodology
Score52 / 100
DesignationNot ranked

Score breakdown

MeasureThis organizationPoints
Operating reserves14.5 mo; 14.4 mo in cash10.1 / 25
Financial balance (median margin)−29.4%2.1 / 20
Transparency3 full 990s, latest TY202420 / 20
Program growth−16.8% / yr0 / 15
Track record24 years9.6 / 10
Debt load0.3% of assets10 / 10
Total51.8 → 52
Spending on programs
Not scored; America's Best needs 65%+
54%Below

Compared with Los Angeles peers

MeasureThis organizationPeer median
Operating reserves14.5 mo14.5 mo
Typical margin−29.4%+4.0%
Spending growth−16.8% / yr+17.0% / yr
Debt load0.3%0.3%

Peers: the 15 Los Angeles medical research organizations with a score, ranked or below the bar.

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$110,733Fiscal year 20242022: $750,98020222023: $377,63520232024: $110,7332024
Expenses$238,586Fiscal year 20242022: $344,61920222023: $534,64520232024: $238,5862024
Total assets$289,010Fiscal year 20242022: $573,87320222023: $416,86320232024: $289,0102024
Total liabilities$980Fiscal year 20242022: $98020222023: $98020232024: $9802024
Fiscal year ending December 2024
Revenue$110,733
Expenses$238,586
Net income−$127,853
Net assets$288,030

Notable sources of revenue

Percent of total revenue
Contributions$97,567
Program services$0
Investment income$13,166
Other (net)$0

Assets / debt

Total assets$289,010
Total liabilities$980
Net assets$288,030

Compensation

Not in our extract for this year.

Fiscal year ending December 2023
Revenue$377,635
Expenses$534,645
Net income−$157,010
Net assets$415,883

Notable sources of revenue

Percent of total revenue
Contributions$359,759
Program services$0
Investment income$17,876
Other (net)$0

Assets / debt

Total assets$416,863
Total liabilities$980
Net assets$415,883

Compensation

Officers and key employees$64,669
Share of expenses12.1%
Fiscal year ending December 2022
Revenue$750,980
Expenses$344,619
Net income$406,361
Net assets$572,893

Notable sources of revenue

Percent of total revenue
Contributions$750,177
Program services$0
Investment income$803
Other (net)$0

Assets / debt

Total assets$573,873
Total liabilities$980
Net assets$572,893

Compensation

Officers and key employees$61,000
Share of expenses17.7%

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?